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INTRODUCTION
Cryptococcosis is an invasive fungal infection caused by two species of Cryptococcus spp. 
Cryptococcus neoformans is commonly related to immunocompromised patients mainly causing 
meningitis. Cryptococcus gattii is encountered in immunocompetent population and it is 
associated with cryptococcoma formation in the brain and lungs.[18] Accordingly, this infection 
is predominantly seen among immunosuppressed patients, typically those with HIV infection 
and from less-developed countries with significant morbidity and mortality.[13] Cryptococcosis 
can also occur in immunologically competent host providing localized reactions.[3] Hence, 
central nervous system (CNS) cryptococcosis could be meningeal (the most frequent) and/
or parenchymal.[18] Cryptococcoma is a chronic granulomatous reaction due to a local 
inflammatory response in the immunocompetent host. Frequently, it may be misdiagnosed as 
a malignant lesion, and an accurate diagnosis can be achieved by histology following surgical 
resection.[19]
ABSTRACT
Background: Central nervous system (CNS) cryptococcosis is an invasive fungal infection predominantly seen 
among immunosuppressed patients causing meningitis or meningoencephalitis. Rarely, cryptococcosis can 
affect immunologically competent hosts with the formation of localized CNS granulomatous reaction, known as 
cryptococcoma. Common symptoms of CNS cryptococcoma are headaches, consciousness or mental changes, 
focal deficits, and cranial nerve dysfunction. Rarely, seizures are the only presenting symptom.
Case Description: We report the case of an immunocompetent patient with a solitary CNS cryptococcoma 
presenting with a long history of non-responsive generalized seizure who has been successfully operated.
Conclusion: CNS cryptococcoma is a rare entity, and in immunocompetent patients, its diagnosis can be 
challenging. e pathophysiology of lesion-related seizure is discussed along with a review of the pertinent 
literature.
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Here, we present the case of an intracranial cryptococcoma 
in a 32-year-old woman with normal immunity. e main 
mechanisms underlying seizure manifestation along with a 
review of the pertinent literature are reported.
CASE DESCRIPTION
A 32-year-old Indian woman presented with a history of 
tonic-clonic seizures since 2013, started during her first 
pregnancy. In 2016, she underwent electroencephalogram 
which confirmed the diagnosis of epilepsy. Accordingly, 
she started antiepileptic treatment with levetiracetam at 
initial daily dose of 1 g. Due to the recurrence of seizures, 
the drug was increased till a daily dose of 1.5 g with a poor 
seizure control. In 2019, a brain magnetic resonance (MR) 
examination revealed a right temporo-mesial lesion with 
an irregular peripheral contrast enhancement. e lesion 
appeared to protrude toward the right cerebral peduncle 
with brainstem compression, highly suggestive of low-grade 
glioma. MR spectroscopy supported the suspicion of glioma. 
e patient underwent functional MR showing anterior 
dislocation of the inferior longitudinal fasciculus. [Figures 1 
and 2] show the main neuroradiological features. At 
admission, the neurological examination was negative. Her 
medical history did not reveal significant features, such as 
recurrent respiratory infection, and contact with pet animals. 
HIV serology was negative.
Surgical procedure
e procedure was performed by the use of neuronavigation. 
A right temporal craniotomy was performed. rough a 
transulcal approach, the lesion was reached. e lesion 
appeared as a calcified mass tenaciously attached to the 
contiguous structures. e lesion was entered, and a yellow-
like material was found densely packing the mass. After a 
careful debulking, the capsule was removed in fragments 
except for its medial part being strictly adherent to the 
brainstem [Video 1].
Histopathology
Histopathology showed multiple yeasts consistent with 
Cryptococcus spp. strongly embedded into an amorphous 
eosinophilic fibrillar material. Period Acid–Schiff and 
mucicarmine stain revealed purple organisms and numerous 
budding yeasts consistent with Cryptococcus spp. [Figures 3 
and 4].
Post-operative course
After surgery, the patient presented with a mild left leg 
coordination impairment which disappeared in a few days. 
Forty-four hours post-operative MRI showed a residual 
capsule fragment adherent to the midbrain [Figure 3]. A total 
body computed tomography (CT) scan and a lumbar puncture 
were performed without evidence of cryptococcal infection. 
Accordingly, no antifungal regimen was introduced. e 
Figure 1: Pre-operative axial (a), coronal (b), and sagittal (c) post-
contrast T1-weighted MR showing a right temporo-mesial lesion 
with an irregular peripheral enhancement.
a b
c
Figure 2: Pre-operative magnetic resonance (MR) spectroscopy (a) 
depicts a low N-acetylaspartate (NAA) with choline (Cho)/NAA 
of 1.33 compared to normal brain parenchyma, suggestive for low-
grade glioma; functional MR (b) showing the anterior dislocation of 
the inferior longitudinal fasciculus (ILF) (red tract) and a unaffected 
corticospinal tracts (blue tracts).
a
b
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patient was discharged on the 7th post-operative day without 
post-operative seizures and neurological deficits. At 6-month 
follow-up, no further seizures were reported.
DISCUSSION
Cryptococcal infection occurs by inhalation of infectious 
propagules from environmental reservoirs and pulmonary 
impairment constitutes the first manifestation.[13] Inhaled 
spores can colonize the host respiratory tract without 
symptoms leading the infection in a latent form for many 
times.[7] When local host immunity is suppressed, the fungus 
can reactivate and widely disseminate to several organs.[13] In 
immunosuppressed patients, Cryptococcus spp. can cross the 
blood–brain barrier (BBB) causing meningitis, encephalitis, 
meningoencephalitis, or ventriculitis. In immunocompetent 
patient, brain cryptococcal infection can present as 
single or multifocal granulomatous reaction known as 
cryptococcoma.[6,7,10,12] To date, only four cases of isolated 
brain cryptococcoma presenting with seizure have been 
reported [Table  1].[2,14,17,22] In two cases, seizure was 
associated with other presenting symptoms.[2] ree cases 
presented with generalized epilepsy,[2,17,22] as in our report, 
while one with focal epilepsy.[14] e working diagnosis 
was mostly brain tumor,[2,17] tuberculoma,[14] or vascular 
malformation.[22] Complete surgical excision was performed 
in 1 case,[17] subtotal in 1 case,[22] and stereotactic biopsy in 2 
cases.[2,14] Post-operative antifungal drugs (i.e., fluconazole 
and amphotericin) were administered for the prevention of 
fulminant cryptococcal meningitis in three cases.[2,14,22] In our 
case, surgical treatment allowed cryptococcoma resection 
leaving a small capsule fragment adherent to the midbrain. 
Furthermore, considering the absence of active infection signs, 
no therapy was introduced.
It has been reported that Cryptococcus spp. enters the 
Virchow–Robin spaces and gives rise to small cysts in the 
brain parenchyma, inducing a chronic granulomatous reaction 
composed by macrophages, lymphocytes, and foreign body-
type giant cells.[5] Cryptococcus spp. is a facultative intracellular 
pathogen, and macrophages can act as both a niche for 
fungal replication and a safe vehicle for spreading into the 
brain.[12,20] Studies on the pathogenesis of epilepsy due to brain 
infection distinguish between early and late seizures.[8] Early 
seizure occurs within the 1st 1–2 weeks after infection and it 
is considered to be insult related. Late seizure is seen months 
to years after infections and it occurs following resolution of 
the active phase.[20] During the phase between the infection 
and onset of seizures, Cryptococcus spp. induces brain damage 
and BBB impairment through the release of pro-inflammatory 
cytokines and activation of downstream signaling promoting 
the innate immunity reaction and later the adaptive immune 
response.[12,20,21] e risk for developing epilepsy after infections 
depends on the severity of brain injury, age, genetic factors, 
and many other unknown variables.[12,20]
Solitary cryptococcoma is a rare lesion,[7] and the absence of 
an immunosuppressed history or significant predisposing 
factors in immunocompetent patients makes the diagnosis 
challenging. In our case, cryptococcoma presented 
as a localized tumor-like mass with a 7-year seizures 
history without other symptoms. Indeed, without a clear 
clinical history, cryptococcoma can appear radiologically 
indistinguishable from other CNS lesions.[7,9,11,15,19] 
Differential diagnosis needs to include other neuroinfectious 
diseases, such as toxoplasmosis, lymphoma, tuberculoma, 
and primary or metastatic tumors.[1,4,15] ese pathologies can 
produce similar clinical syndromes and MRI or CT findings 
to cryptococcoma. 
Figure  3: e histopathological findings. (a-c) Cryptococcus 
embedded in an amorphous eosinophilic fibrillary background. 
Cryptococcus is a round budding yeast (arrows) that varies in size 
enveloped by a mucoid capsule (E and E ×20); (d) focus on a cluster 
of Cryptococcus (arrows) (E and E ×40).
a b
dc
Figure  4: (a-c) Period Acid–Schiff staining the amorphous 
eosinophilic background and, weakly, the yeasts of Cryptococcus 
(arrows) (E, F ×20; G ×40); (d) Mucicarmine staining, patchy and 
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In CNS cryptococcal infection, a combined medical and 
surgical approach is considered the optimal treatment.[18] 
Systemic antifungal treatment consists of amphotericin B as 
first-line drug, and flucytosine or fluconazole as second-class 
agents.[16,18]
According to our experience and based on the few reports 
available, we speculate that surgical resection should be 
always attempted to reach a firm diagnosis and brain 
decompression.[19]
CONCLUSION
CNS cryptococcoma is a rare entity and could affect 
immunocompetent individuals. It has no specific radiologic 
findings and can mimic CNS tumors. Our experience 
suggests that in immunocompetent patients, an isolated 
intracerebral cryptococcal granuloma can be challenging to 
diagnose where seizure is the only presenting symptom. In 
these cases, surgical treatment is mandatory for the diagnosis 
and seizure resolution.
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